PMID- 31006100 OWN - NLM STAT- MEDLINE DCOM- 20191216 LR - 20200225 IS - 1573-4978 (Electronic) IS - 0301-4851 (Linking) VI - 46 IP - 4 DP - 2019 Aug TI - Yangyin Tongnao granules enhance neurogenesis in the peri-infarct area and upregulate brain-derived neurotrophic factor and vascular endothelial growth factor after focal cerebral ischemic infarction in rats. PG - 3817-3826 LID - 10.1007/s11033-019-04824-5 [doi] AB - Yangyin Tongnao granules (YYTNG) have been extensively applied in the treatment of brain injury, mainly due to its antioxidant effects, inhibition of apoptosis, and enhancement of blood circulation. To analyze the effect of YYTNG on the recovery of neurological function and neurogenesis in the peri-infarct area after cerebral ischemic infarction in rats and to elucidate its role in the neuroprotective mechanism of stroke, Sprague-Dawley (SD) rats were subjected to middle cerebral artery occlusion (MCAO) for 90 min followed by reperfusion. Rats were randomly divided into five groups: sham, MCAO, and YYTNG-treated rats given doses of 0.83, 1.65, or 3.3 g kg(-1) day(-1). The YYTNG-treated groups (1.65 and 3.3 g kg(-1) day(-1)) showed higher neurological scores and a lower infarct volume than the MCAO group on day 3 after MCAO. Furthermore, the YYTNG-treated groups (0.83, 1.65, and 3.3 g kg(-1) day(-1)) showed higher neurological scores on day 7 after MCAO. The number of BrdU(+)/nestin(+), BrdU(+)/NeuN(+), and BrdU(+)/GFAP(+) cells in the peri-infarct area 7 days after MCAO was significantly increased in the YYTNG-treated groups in a dose-dependent manner. The protein expression levels of brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) were significantly higher in all three YYTNG-treated groups than in the MCAO group. Based on these results, administration of YYTNG post ischemia could ameliorate neurological function deficits in rats with MCAO. The therapeutic effect of YYTNG may be due to the promotion of neurogenesis in the peri-infarct area and the upregulation of neuroprotective factors BDNF and VEGF in MCAO rats. FAU - Wang, Yu AU - Wang Y AUID- ORCID: 0000-0001-7894-6523 AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. FAU - Yang, Jiehong AU - Yang J AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. FAU - Du, Haixia AU - Du H AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. FAU - Zhang, Hongbo AU - Zhang H AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. FAU - Wan, Haitong AU - Wan H AUID- ORCID: 0000-0001-5726-7214 AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. haitongw@163.com. FAU - He, Yu AU - He Y AD - Zhejiang Chinese Medical University, Hangzhou, 310053, China. heyu0923@hotmail.com. LA - eng GR - 81630105/National Natural Science Foundation of China/ GR - LZ17H270001/Zhejiang Provincial Natural Science Foundation of China/ PT - Journal Article DEP - 20190420 PL - Netherlands TA - Mol Biol Rep JT - Molecular biology reports JID - 0403234 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Vascular Endothelial Growth Factor A) SB - IM MH - Animals MH - Astrocytes MH - Brain Ischemia/*drug therapy/metabolism MH - Brain-Derived Neurotrophic Factor/*metabolism MH - Cell Differentiation/drug effects MH - Infarction, Middle Cerebral Artery/*drug therapy/metabolism MH - Neurogenesis/*drug effects MH - Rats MH - Rats, Sprague-Dawley MH - Vascular Endothelial Growth Factor A/*metabolism OTO - NOTNLM OT - BDNF OT - NPCs OT - Neurogenesis OT - VEGF OT - Yangyin Tongnao granules EDAT- 2019/04/22 06:00 MHDA- 2019/12/18 06:00 CRDT- 2019/04/22 06:00 PHST- 2019/01/29 00:00 [received] PHST- 2019/04/13 00:00 [accepted] PHST- 2019/04/22 06:00 [pubmed] PHST- 2019/12/18 06:00 [medline] PHST- 2019/04/22 06:00 [entrez] AID - 10.1007/s11033-019-04824-5 [pii] AID - 10.1007/s11033-019-04824-5 [doi] PST - ppublish SO - Mol Biol Rep. 2019 Aug;46(4):3817-3826. doi: 10.1007/s11033-019-04824-5. Epub 2019 Apr 20.